Back to the solutions

Smart liquid biopsy panels with selected key genes per tumor type

Order an OncoSELECT

I am a patient

See how our solutions can help you in the treatment of cancer.

See case reports

OncoSELECT Solution

OncoSELECT is a fast, minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colon and breast (ER+ or HER2+) cancer patients.
It is the perfect tool to identify therapeutic solutions for cancer patients not able to get their tumor biopsied, to monitor the progression of their cancer and to detect treatment resistance as soon as it appears.

 

Description

Following a recent change in FDA guidelines, a liquid biopsy is now approved as the first diagnostic tool for non-small cell lung cancer patients. OncoSELECT is the perfect test to do a first screening of the most relevant genes related to treatments.

OncoSELECT targets more than 100 resistance mutations and sensitivity to targeted therapies (SNVs,indels, translocation and CNVs) as well as specific genes selected for each cancer type.

Download the product sheet

Download the genes panel

Advantages

To select a therapy : Mainly for patients whose tissue sample is not available or is limited, when it is challenging or not possible to perform a biopsy of the primary tumor or of any metastases, or if the biopsy sample is too old.

As a monitoring tool : It is the right way to monitor tumor response to the treatment, detect potential resistance, adapt the treatment and, by doing so, extend the patient’s life. It is fast, minimally invasive for the patient and more sensitive than routine imaging.

 

Logistics

Just send us a blood sample (2 Streck tubes each containing 10 ml).

Download sample prep protocol

 

 

How much does OncoSELECT cost?

Price

Please inquire for country specific price information for this solution, please send an email at this address: sales@oncodna.com

Reimbursement statement

Our tests are currently reimbursed in a growing number of countries. In the United Kingdom, OncoSTRAT&GO is reimbursed for patients insured by BUPA Global Insurance, using code 7331B. Other countries, like Spain, Chili, South Africa and Poland, also cover the cost of our tests, either totally or partially. Don’t hesitate to contact us for more information.

How can I get OncoSELECT?

Ordering a solution is very simple: just log into OncoSHARE, and select your solution(s). If you don’t have a kit, we’ll send you one. After interpretation by our expert team thean interactive report iswill be available for you on OncoSHARE. You can review, edit and/or share it.

See more about OncoSHARE

Order an OncoSELECT
The case report

Alicia, 49 years old when diagnosed

Was given the OncoDEEP solution following a stage 3 lung cancer.

View Alicia's report